Global End Stage Renal Disease Market Size & Outlook

The end stage renal disease industry worldwide is expected to reach a projected revenue of US$ 261,639.2 million by 2030. A compound annual growth rate of 13% is expected of the worldwide end stage renal disease industry from 2024 to 2030.
Revenue, 2023 (US$M)
$111,217.4
Forecast, 2030 (US$M)
$261,639.2
CAGR, 2024 - 2030
13%
Report Coverage
Worldwide

Global end stage renal disease market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Global end stage renal disease market highlights

  • The global end stage renal disease market generated a revenue of USD 111,217.4 million in 2023 and is expected to reach USD 261,639.2 million by 2030.
  • The market is expected to grow at a CAGR (2024 - 2030) of 13% by 2030.
  • In terms of segment, dialysis accounted for a revenue of USD 86,286.3 million in 2023.
  • Dialysis is the most lucrative treatment type segment registering the fastest growth during the forecast period.
  • In terms of region, Asia Pacific was the largest revenue generating market in 2023.
  • Country-wise, Germany is expected to register the highest CAGR from 2024 to 2030.

Global data book summary

Market revenue in 2023USD 111,217.4 million
Market revenue in 2030USD 261,639.2 million
Growth rate13% (CAGR from 2023 to 2030)
Largest segmentDialysis
Fastest growing segmentDialysis
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTransplant, Dialysis

Other key industry trends

  • In terms of revenue, the North America accounted for 16.0% of the global end stage renal disease market in 2023.
  • By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
  • By country, Germany is the fastest growing regional market and is projected to reach USD 4,986.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

End Stage Renal Disease Market Companies

Name Profile # Employees HQ Website

Global end stage renal disease market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to end stage renal disease market will help companies and investors design strategic landscapes.


Dialysis was the largest segment with a revenue share of 77.58% in 2023. Horizon Databook has segmented the Global end stage renal disease market based on transplant, dialysis covering the revenue growth of each sub-segment from 2018 to 2030.


  • Global End Stage Renal Disease Treatment Type Outlook (Revenue, USD Million, 2018-2030)
    • Transplant
    • Dialysis
      • Peritoneal Dialysis
      • Hemodialysis
      • Wearable Artificial Kidney

Reasons to subscribe to Global end stage renal disease market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Global end stage renal disease market databook

  • Our clientele includes a mix of end stage renal disease market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of global-level data and insights on the Global end stage renal disease market , including forecasts for subscribers. This global databook contains high-level insights into Global end stage renal disease market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Global end stage renal disease market size, by regions, 2018-2030 (US$M)

Top 10 countries: End stage renal disease market size, 2023 (US$M)

Global end stage renal disease market share, by treatment type, 2023 & 2030 (%, US$M)

End stage renal disease market: Opportunity assessment by country

Global end stage renal disease market, by region, 2023 (US$M)

Global end stage renal disease market size, by regions, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more